According to a new report, published by KBV research, The Global Nucleic Acid Isolation and Purification Market size is expected to reach $11.5 billion by 2030, rising at a market growth of 9.2% CAGR during the forecast period.
The Drug Discovery & Development segment is experiencing a CAGR of 9.7% during (2023 - 2030). Nucleic acid isolation and purification are fundamental processes in drug discovery, aiding in the identification, validation, and understanding of potential drug targets, biomarkers, and therapeutic agents. Drug discovery involves screening numerous compounds for their efficacy against specific targets. Nucleic acid isolation and purification technologies facilitate HTS, allowing rapid screening of compounds for their effects on nucleic acid-based targets.
The Kits segment is registering maximum revenue in the Global Nucleic Acid Isolation and Purification Market by Product in 2022; thereby, achieving a market value of $4.8 billion by 2030. Nucleic acid extraction kits offer user-friendly protocols, reducing the complexity and variability associated with manual extraction methods. They come with step-by-step instructions, pre-measured reagents, and optimized protocols, making them accessible to many users, from researchers to clinicians.
The Column Based segment would exhibit a CAGR of 9.7% during (2023 - 2030). Column-based isolation methods are known for providing high-quality, pure nucleic acids. These techniques efficiently remove impurities and contaminants, ensuring the extracted nucleic acids are of superior quality. Researchers and clinicians often prefer column-based methods for applications where purity and yield are critical, such as in PCR, sequencing, and diagnostics.
The Plasmid DNA Isolation & Purification segment is generating the highest revenue in the Global Nucleic Acid Isolation and Purification Market by Type in 2022; thereby achieving a market value of $3.5 billion by 2030. The rapid evolution of biotechnology has fostered the demand for plasmid DNA in genetic manipulation and recombinant DNA technology, requiring efficient and high-quality isolation and purification techniques. With the rise in biopharmaceutical production and recombinant protein manufacturing, the need for plasmid DNA for gene therapy has surged, boosting the demand for effective isolation and purification methods.
The Pharmaceutical & Biotechnology Companies segment is anticipated to grow at a CAGR of 9.4% during (2023 - 2030). Pharmaceutical and biotech firms often conduct diagnostics as part of their research and development processes. Accurate diagnostics require high-quality nucleic acid samples from reliable isolation and purification methods. These applications can range from identifying biomarkers and disease-specific genetic variations to evaluating drug responses or treatment efficacy. These aspects will pose lucrative growth prospects in the segment.
The North America region is leading the segment in the Global Nucleic Acid Isolation and Purification Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $4.2 billion by 2030. The Europe region is experiencing a CAGR of 8.8% during (2023 - 2030). Additionally, The Asia Pacific region would exhibit a CAGR of 10% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/nucleic-acid-isolation-and-purification-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad laboratories, Inc., Illumina, Inc., and New England Biolabs, Inc.
By Application
By Product
By Method
By Type
By End User
By Geography
Companies Profiled
Unique Offerings 
